药品集中采购政策对某院口服降糖药使用情况的影响

Influence of Centralized Drug Purchasing Policy on the Use of Oral Hypoglycemic Drugs in One Hospital

目的分析第二、第三批国家药品集中采购实施后对莆田某三甲医院(以下简称某院)口服降糖药使用的影响,为国家集采药品政策的优化提供参考。方法选取第二批集采药品执行前后1 a(即2019年4月24日至2020年4月23日,2020年4月24日至2021年4月23日)口服降糖药使用相关数据,数据导出后用Excel统计出用药频度(DDDs)、日均费用(DDC)及其变化幅度等,并进行回顾性分析。结果集采政策执行后,口服降糖药总使用量同比增加38.27%,使用金额下降21.19%,节省药品费用334万余元;二甲双胍、阿卡波糖、格列美脲3种药品的DDDs同比增加,DDC降低,体现出“价降量升”线性关系。结论国家集采政策的实施对口服降糖药的使用呈现不同影响,大部分药品的日均费用降低,有效降低患者的药费负担。

Objective To analyze the impact of the second and third batches of national centralized drug procurement on oral hypoglycemic drugs in a tertiary A hospital in Putian,so as to provide reference for clinical rational drug use and optimization of the national centralized drug purchase policy.Methods One year before and after the implementation of the second batch of centralized drugs data was selected(from April 24,2019 to April 23,2020,and from April 24,2020 to April 23,2021).After the data was exported,defined daily dose system(DDDs),defined daily cost(DDC)and its variation range were calculated using Excel,and a retrospective analysis was carried out.Results After the implementation of the centralized purchasing policy,the total usage of oral hypoglycemic drugs increased by 38.27%year-on-year,the amount used decreased by 21.19%,and the drug cost was saved by more than 3.34 million yuan.The DDDs of metformin,acarbose and glimepiride increased year-on-year,the DDC value decreased,reflecting the linear relationship of“price drop and volume increase”.Conclusion The implementation of the national centralized procurement policy has different effects on the use of oral hypoglycemic drugs.The average daily cost of most drugs is reduced,which effectively reduces the drug cost burden of patients and provides a reference for optimizing the policy.